A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy

被引:110
作者
Tateishi, T
Nakura, H
Asoh, M
Watanabe, M
Tanaka, M
Kumai, T
Takashima, S
Imaoka, S
Funae, Y
Yabusaki, Y
Kamataki, T
Kobayashi, S
机构
[1] NATL INST NEUROSCI,DEPT MENTAL RETARDAT & BIRTH DEFECT RES,TOKYO,JAPAN
[2] OSAKA CITY UNIV,SCH MED,CHEM LAB,OSAKA 545,JAPAN
[3] SUMITOMO CHEM CO LTD,BIOTECHNOL LAB,HYOGO,JAPAN
[4] HOKKAIDO UNIV,FAC PHARMACEUT SCI,DIV DRUG METAB,SAPPORO,HOKKAIDO 060,JAPAN
关键词
hepatic cytochrome P450; Western blotting; perinatal period; infancy; postinfancy;
D O I
10.1016/S0024-3205(97)01011-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We immunochemically measured the contents of 9 different cytochrome P450 (CYP) isoenzymes expressed in the liver and compared them between two groups: one group of 6 infant and 4 perinatal patients and one group of 10 patients after infancy (over 1 year old). CYP protein expressed in human liver can be divided into three groups on the basis of expression pattern: (a) CYP2A6, 2C9, 2D6, 2E1, and 3A were present in all samples and no difference was observed between the two groups; (b) CYP1A2, 2B6, and 2C8 were expressed more after infancy than during infancy; and (c) CYP3A7, which has been considered a major CYP enzyme in fetal liver microsomes, was expressed in all infants as well as the four perinatal patients, whereas it was detected in only 2 patients after infancy. These results implied that CYP2A6, 2C9, 2D6, 2E1, and 3A are already expressed during perinatal and infant period, while CYP1A2, 2B6, and 2C8 are expressed highly in subjects over 1 year old, and CYP3A7 disappeared after infancy.
引用
收藏
页码:2567 / 2574
页数:8
相关论文
共 32 条
[1]   CAFFEINE AND THEOPHYLLINE METABOLISM IN NEWBORN AND ADULT HUMAN HEPATOCYTES - COMPARISON WITH ADULT-RAT HEPATOCYTES [J].
BERTHOU, F ;
RATANASAVANH, D ;
ALIX, D ;
CARLHANT, D ;
RICHE, C ;
GUILLOUZO, A .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (19) :3691-3700
[2]  
Carpenter SP, 1996, MOL PHARMACOL, V49, P260
[3]  
CARRIER O, 1988, CLIN PHARMACOL THER, V25, P447
[4]   BIOTRANSFORMATION OF CAFFEINE IN HUMAN LIVER-MICROSOMES FROM FETUSES, NEONATES, INFANTS AND ADULTS [J].
CAZENEUVE, C ;
PONS, G ;
REY, E ;
TRELUYER, JM ;
CRESTEIL, T ;
THIROUX, G ;
DATHIS, P ;
OLIVE, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (05) :405-412
[5]   IMMUNOQUANTIFICATION OF EPOXIDE HYDROLASE AND CYTOCHROME-P-450 ISOZYMES IN FETAL AND ADULT HUMAN-LIVER MICROSOMES [J].
CRESTEIL, T ;
BEAUNE, P ;
KREMERS, P ;
CELIER, C ;
GUENGERICH, FP ;
LEROUX, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 151 (02) :345-350
[6]   MIDAZOLAM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE [J].
DUNDEE, JW ;
HALLIDAY, NJ ;
HARPER, KW ;
BROGDEN, RN .
DRUGS, 1984, 28 (06) :519-543
[7]   EFFECT OF AGE ON PATTERNS OF THEOPHYLLINE METABOLISM [J].
GRYGIEL, JJ ;
BIRKETT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :456-462
[8]   ESTIMATION OF ISOZYMES OF MICROSOMAL CYTOCHROME-P-450 IN RATS, RABBITS, AND HUMANS USING IMMUNOCHEMICAL STAINING COUPLED WITH SODIUM DODECYL-SULFATE POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
GUENGERICH, FP ;
WANG, P ;
DAVIDSON, NK .
BIOCHEMISTRY, 1982, 21 (07) :1698-1706
[9]   PURIFICATION AND CHARACTERIZATION OF LIVER MICROSOMAL CYTOCHROMES-P-450 - ELECTROPHORETIC, SPECTRAL, CATALYTIC, AND IMMUNOCHEMICAL PROPERTIES AND INDUCIBILITY OF 8 ISOZYMES ISOLATED FROM RATS TREATED WITH PHENOBARBITAL OR BETA-NAPHTHOFLAVONE [J].
GUENGERICH, FP ;
DANNAN, GA ;
WRIGHT, ST ;
MARTIN, MV ;
KAMINSKY, LS .
BIOCHEMISTRY, 1982, 21 (23) :6019-6030
[10]  
GUENGERICH FP, 1989, ANN REV PHARM TOXICO, V29, P442